In contrast to previous reports, using cell lines or B cells of SLE patients (2, 33), we demonstrate that in healthy donors, the IRF5 risk and non-risk haplotypes are not differentially expressed in B cells in the resting state or after TLR activation. The gene discussed is IRF5; the disease is systemic lupus erythematosus.